Search
 
1    2    3    4   
Press Releases
May 17, 2012
Generex Announces New Members of Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine
May 15, 2012
Generex Enhances Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine with Renowned Breast Cancer Researchers
May 09, 2012
Generex Announces Establishment of a Scientific Advisory Board for Antigen Express
All releases
Webcast Events and Media
  Second Annual "Cancer Immunotherapy: A Long-Awaited Reality" Conference at the New York Academy of Medicine
- Oct 06, 2011

  Rodman & Renshaw 13th Annual Healthcare Conference
- Sep 12, 2011

  Generex 2011 Annual Meeting
- Jun 08, 2011

  Generex Biotechnology Corporation CEO to Present Live, Online at RetailInvestorConferences.com
- May 05, 2011

  Generex Live Video Webcast from the NASDAQ MarketSite
- Oct 21, 2010

  Generex Coporate Update
- Oct 12, 2010


Print Print     Email Email page

Investor Home


Investor Relations

For more information please contact:
Todd Falls
Tel: 1-800-391-6755
Fax: (647) 547-7104
Email: tfalls@generex.com


Exchange

OTC Bulletin Board

Listed Security

GNBT Common Stock

Transfer Agent

StockTrans, Inc.
44 West Lancaster Avenue
Ardmore, PA 19003
Phone 610-649-7300
Fax 610-649-7302

Corporate Counsel

Eckert Seamans Cherin & Mellott, LLC
1515 Market Street, 9th Floor
Philadelphia, PA 19102
Phone 215-851-8447
Fax 215-851-8383


Stock Quote
OTC BB: GNBT        0.10
17 May 2012    3:52 PM ET
Investor Tool Kit
PDF Corporate Fact Sheet
PDF Investor Presentation

Privacy Policy